Cargando…

Immunomodulatory and immunosuppressive medication modification among patients with rheumatic diseases at the time of COVID-19 vaccination

Detalles Bibliográficos
Autores principales:	Barbhaiya, Medha, Levine, Jonah M, Bykerk, Vivian P, Mandl, Lisa A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2022
Materias:	Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8651251/ https://www.ncbi.nlm.nih.gov/pubmed/34901886 http://dx.doi.org/10.1016/S2665-9913(21)00372-6

Ejemplares similares

Modification of immunomodulatory medications by rheumatology patients during the peak of the COVID-19 pandemic in New York City
por: Barbhaiya, Medha, et al.
Publicado: (2022)

Adverse events and disease flares after SARS-CoV-2 vaccination in patients with systemic lupus erythematosus
por: Barbhaiya, Medha, et al.
Publicado: (2021)

The efficacy and safety of targeting GM-CSF in arthritis
por: Bykerk, Vivian P
Publicado: (2020)

COVID-19 vaccine acceptance over time in patients with immune-mediated inflammatory rheumatic diseases
por: Boekel, Laura, et al.
Publicado: (2022)

Vaccination against COVID-19: Expectations and concerns of patients with autoimmune and rheumatic diseases
por: Felten, Renaud, et al.
Publicado: (2021)

Diagnosis of acute rheumatic carditis: An echo in time…
por: Karthikeyan, Ganesan
Publicado: (2012)

Factors associated with poor antibody response to third-dose SARS-CoV-2 vaccination in patients with rheumatic and musculoskeletal diseases
por: Connolly, Caoilfhionn M, et al.
Publicado: (2022)

Acceptability of the COVID-19 vaccine among patients with chronic rheumatic diseases and health-care professionals: a cross-sectional study in 19 Arab countries
por: El Kibbi, Lina, et al.
Publicado: (2022)

Rheumatic Disease-Related Symptoms During the Height of the COVID-19 Pandemic
por: Mancuso, Carol A., et al.
Publicado: (2020)

Humoral response following SARS-CoV-2 vaccination: not all immunosuppressants are created equal
por: Connolly, Caoilfhionn M, et al.
Publicado: (2022)

Protecting the vulnerable: SARS-CoV-2 vaccination in immunosuppressed patients with interstitial lung disease
por: Mackintosh, John A, et al.
Publicado: (2021)

Antibody durability 6 months after two doses of SARS-CoV-2 mRNA vaccines in patients with rheumatic and musculoskeletal disease
por: Frey, Sarah, et al.
Publicado: (2022)

Importance of nociplastic pain in patients with rheumatic diseases
por: Alcántara Montero, Antonio
Publicado: (2023)

Hybrid immunity versus vaccine-induced immunity against SARS-CoV-2 in patients with autoimmune rheumatic diseases
por: Shenoy, Padmanabha, et al.
Publicado: (2022)

Post-COVID-19 condition in patients with autoimmune rheumatic diseases: the COVID-19 Vaccination in Autoimmune Diseases (COVAD) study
por: Sen, Parikshit, et al.
Publicado: (2023)

Reply to the comment on “Accuracy and usability of a diagnostic decision support system in the diagnosis of three representative rheumatic diseases: a randomized controlled trial among medical students”
por: Knitza, Johannes, et al.
Publicado: (2022)

Effect of the COVID-19 pandemic on patients with systemic rheumatic diseases
por: Antonelli, Alessandro, et al.
Publicado: (2021)

COVID-19 in patients with rheumatic disease: finally, a denominator
por: Wallace, Daniel J
Publicado: (2021)

Long COVID in inflammatory rheumatic diseases—what's in a name?
por: Calabrese, Leonard H
Publicado: (2023)

COVID-19: implications for immunosuppression in kidney disease and transplantation
por: Kronbichler, Andreas, et al.
Publicado: (2020)

Immunosuppression and SARS-CoV-2 breakthrough infections
por: Kim, Alfred H J, et al.
Publicado: (2022)

Managing patients with rheumatic diseases treated with rituximab during the COVID-19 pandemic
por: Dougados, Maxime
Publicado: (2021)

Baricitinib: the first immunomodulatory treatment to reduce COVID-19 mortality in a placebo-controlled trial
por: Kalil, Andre C, et al.
Publicado: (2021)

Changing COVID-19 outcomes in patients with rheumatic disease—are we really getting better at this?
por: Gianfrancesco, Milena A, et al.
Publicado: (2021)

Real-world evidence for prehospital COVID-19 treatment in systemic autoimmune rheumatic disease
por: Bechman, Katie, et al.
Publicado: (2023)

First data on COVID-19 morbidity and mortality in patients with rheumatic disease from South Korea
por: Schreiber, Karen, et al.
Publicado: (2021)

Universal coronavirus vaccines: the time to start is now
por: Giurgea, Luca T., et al.
Publicado: (2020)

Time to redefine a primary vaccination series?
por: Tanriover, Mine Durusu, et al.
Publicado: (2022)

Is it safe to vaccinate rheumatic immunosuppressed patients? Yes, of course, but how?
por: Gillet, Pierre
Publicado: (2021)

Patients with rheumatic diseases adhere to COVID-19 isolation measures more strictly than the general population
por: Hooijberg, Femke, et al.
Publicado: (2020)

Beyond vaccine hesitancy: time for Africa to expand vaccine manufacturing capacity amidst growing COVID-19 vaccine nationalism
por: Otu, Akaninyene, et al.
Publicado: (2021)

Anthroponosis and risk management: a time for ethical vaccination of wildlife?
por: Edwards, Sarah JL, et al.
Publicado: (2021)

Challenges to medical education at a time of physical distancing
por: Gill, Deborah, et al.
Publicado: (2020)

Distinct immune response to CoronaVac in SARS-CoV-2 seropositive and seronegative patients with autoimmune rheumatic disease
por: Gao, Xing-Su, et al.
Publicado: (2022)

COVID-19 vaccines: breaking record times to first-in-human trials
por: Kim, Young Chan, et al.
Publicado: (2020)

Rethinking vaccine hesitancy among minority groups
por: Khan, Mishal S, et al.
Publicado: (2021)

Addressing vaccine inequities among Ukrainian refugees
por: Hill, Matilda, et al.
Publicado: (2022)

Early in the epidemic: impact of preprints on global discourse about COVID-19 transmissibility
por: Majumder, Maimuna S, et al.
Publicado: (2020)

Hospitalisation among vaccine breakthrough COVID-19 infections
por: Juthani, Prerak V, et al.
Publicado: (2021)

COVID-19, rheumatic diseases and immunosuppressive drugs: an appeal for medication adherence
por: Venerito, Vincenzo, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ljn08r11r4njgbnmqhjctnsthm